SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* HAYWOOD GEORGE WEAVER (Last) (First) (Middle) MOOMJIAN, WAITE, WACTLAR & COLEMAN, LLP 100 JERICHO QUADRANGLE, SUITE 225 (Street) JERICHO NY 11753 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/16/2010	3. Issuer Name and Ticker or Trading Symbol AVI BIOPHARMA INC [ AVII ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) X Other (specify below) May be deemed 10% group member	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,329,126	D(1)
Common Stock	1,000,000	D(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants (Right to Buy)	02/25/2010	08/25/2014	Common Stock	160,000	1.78	D(1)
Warrants (Right to Buy)	06/20/2008	12/18/2012	Common Stock	1,315,673	2.45	D(1)

1. Name and Address of Reporting Person* HAYWOOD GEORGE WEAVER (Last) (First) (Middle) MOOMJIAN, WAITE, WACTLAR & COLEMAN, LLP 100 JERICHO QUADRANGLE, SUITE 225 (Street) JERICHO NY 11753 (City) (State) (Zip)

1. Name and Address of Reporting Person* Haywood Cheryl (Last) (First) (Middle) MOOMJIAN, WAITE, WACTLAR & COLEMAN, LLP 100 JERICHO QUADRANGLE, SUITE 225 (Street) JERICHO NY 11753 (City) (State) (Zip)

Explanation of Responses:

1. These securities are owned solely by George W. Haywood, who may be deemed a member of a "group" with Cheryl Haywood, Rockall Emerging Markets Master Fund Ltd., Meldrum Asset Management, LLC, Mr. Con Egan and Mr. Conor O'Driscoll for purposes of Section 13(d) of the Exchange Act.

2. These securities are owned solely by Cheryl Haywood.

	/s/ George W. Haywood	03/25/2010
	/s/ Cheryl Haywood	03/25/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.